{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:57:15Z","timestamp":1782266235206,"version":"3.54.5"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Solar urticaria (SolU) is a rare chronic inducible urticaria and photodermatosis, presenting with wheal\/flare formation accompanied by severe itch, following exposure to light in the triggering action spectrum. Therapeutic options remain limited for SolU, and the perspective of patients regarding the efficacy of available treatments remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with SolU, organized in a disease-specific Facebook group, were asked to complete an electronic questionnaire on their condition and therapies performed between May 2023 and April 2024. The certainty of SolU diagnosis was differentiated as i) physician confirmed by clinical presentation, ii) light provocation tests, or iii) patient-reported. Study outcomes included clinical presentation, triggering action spectrum, disease severity, impairment of quality of life, therapies performed, and their efficacy. Logistic regression models were used to study the association between clinical factors and treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 112 patients (female, n = 94; median age, 42 years) participated in the study. Most patients considered their condition severe or extremely severe (n = 72, 76.6%) with a very\/extremely impacted quality of life (n = 82, 86.3%). The majority of patients received non-sedating antihistamines (58.9%, n = 66), leading to worsening, no change, or only slight improvement in most cases (82.2%, n = 53). Omalizumab was given to 28 patients and induced complete control in 32.1% of cases. Treatments with sedating antihistamines, ciclosporin, systemic corticosteroids, phototherapy, and\n                      <jats:italic>Polypodium leucotomos<\/jats:italic>\n                      were performed in a residual number of patients and did not lead to a substantial improvement of the symptoms. Antihistamines were more effective in patients with mild disease, whereas omalizumab maintained a positive response across different disease severity levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SolU is generally perceived as severe by affected patients, leading to a high impairment of quality of life. Performed therapies, including off-label treatments, are not sufficient to reach complete remission of symptoms in the majority of patients. Effective therapeutics for SolU are urgently needed to achieve better care for this highly burdened patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1683524","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:12:40Z","timestamp":1762240360000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Current treatment practices and efficacy in solar urticaria: insights from a patient survey"],"prefix":"10.3389","volume":"16","author":[{"given":"Lea","family":"Kiefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Aulenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Terhorst-Molawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Gim\u00e9nez-Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Gon\u00e7alo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emek","family":"Kocat\u00fcrk G\u00f6nc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokvalai","family":"Kulthanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"McSweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"R\u00f6ckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley E.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel P.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.01.039","article-title":"Systematic review of the clinical characteristics and natural history of solar urticaria","volume":"89","author":"McSweeney","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-024-01160-y","article-title":"New insights into chronic inducible urticaria","volume":"24","author":"Munoz","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12543","article-title":"Comparison of racial distribution of photodermatoses in USA academic dermatology clinics: A multicenter retrospective analysis of 1080 patients over a 10-year period","volume":"36","author":"Hamel","year":"2020","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12385","article-title":"Solar urticaria in 145 patients: Assessment of action spectra and impact on quality of life in adults and children","volume":"34","author":"Haylett","year":"2018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1039\/c2pp25177a","article-title":"Photodermatoses: environmentally induced conditions with high psychological impact","volume":"12","author":"Rizwan","year":"2013","journal-title":"Photochem Photobiol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08581.x","article-title":"The quality of life of 790 patients with photodermatoses","volume":"159","author":"Jong","year":"2008","journal-title":"Br J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA(2)LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13960","article-title":"Real-life experience in the treatment of solar urticaria: retrospective cohort study","volume":"44","author":"Snast","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/164_2021_506","article-title":"The classification, pathogenesis, diagnostic workup, and management of urticaria: an update","volume":"268","author":"Maurer","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llae074","article-title":"\u2018Omalizumab changed my life\u2019: a patient perspective on solar urticaria","volume":"49","author":"Parkin","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/phpp.12434","article-title":"Evaluating patient responses to omalizumab in solar urticaria","volume":"35","author":"Griffin","year":"2019","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.06.032","article-title":"Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence","volume":"141","author":"Maurer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/all.16334","article-title":"Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study","volume":"80","author":"Soegiharto","year":"2025","journal-title":"Allergy"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19425","article-title":"Omalizumab for the treatment of chronic inducible urticaria in 80 patients","volume":"184","author":"Exposito-Serrano","year":"2021","journal-title":"Br J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"adv25576","DOI":"10.2340\/actadv.v104.25576","article-title":"Solar urticaria: an ambispective study in a long-term follow-up cohort with emphasis on therapeutic predictors and outcomes","volume":"104","author":"Pesque","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.11.021","article-title":"Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study","volume":"74","author":"Aubin","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12447","article-title":"Successful treatment of solar urticaria with UVA1 hardening in three patients","volume":"35","author":"Lyons","year":"2019","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10104.x","article-title":"Systemic photoprotection in solar urticaria with alpha-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-alpha-MSH","volume":"164","author":"Haylett","year":"2011","journal-title":"Br J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jaad.2014.07.023","article-title":"Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study","volume":"71","author":"Aubin","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B20","article-title":"Oral polypodium leucotomos extract photoprotective activity in 57 patients with idiopathic photodermatoses","volume":"146","author":"Caccialanza","year":"2011","journal-title":"G Ital Dermatol Venereol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14493","article-title":"Pathogenesis of solar urticaria: Classic perspectives and emerging concepts","volume":"31","author":"McSweeney","year":"2022","journal-title":"Exp Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1683524\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:12:41Z","timestamp":1762240361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1683524\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2025.1683524"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1683524","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"1683524"}}